[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100658121":3},{"organization":4,"outcomesModule":7,"designInfo":30,"detailedDescription":33,"studyPopulation":34,"armGroups":35,"interventions":29,"overallOfficials":42,"centralContacts":47,"locations":29,"responsibleParty":53,"collaborators":29,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":29,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":29,"enrollmentInfo":66,"targetDuration":29,"studyType":69,"phases":29,"briefSummary":70,"conditions":71,"keywords":74,"overallStatus":80,"whyStopped":29,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":29},{"fullName":5,"class":6},"Assiut University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":29},[9],{"measure":10,"description":11,"timeFrame":12},"Mean platelet volume in patients with and without vascular complications","Mean platelet volume (MPV) in femtoliters compared between type 2 diabetes patients with vascular complications and those without vascular complications.","Baseline",[14,17,20,23,26],{"measure":15,"description":16,"timeFrame":12},"Mean platelet distribution width","Mean platelet distribution width (PDW) compared between patients with and without vascular complications.",{"measure":18,"description":19,"timeFrame":12},"Distribution of ABO blood groups according to vascular complications","Frequency and percentage of ABO blood groups in patients with and without vascular complications.",{"measure":21,"description":22,"timeFrame":12},"Mean platelet volume according to ABO blood group","Mean platelet volume (MPV) among different ABO blood groups.",{"measure":24,"description":25,"timeFrame":12},"Prevalence of microvascular complications","Proportion of patients with microvascular complications (retinopathy, nephropathy, or neuropathy).",{"measure":27,"description":28,"timeFrame":12},"Prevalence of macrovascular complications","Proportion of patients with macrovascular complications (coronary artery disease, cerebrovascular disease, or peripheral arterial disease).",null,{"allocation":29,"interventionModel":29,"interventionModelDescription":29,"primaryPurpose":29,"observationalModel":31,"timePerspective":32,"maskingInfo":29},"CASE_CONTROL","CROSS_SECTIONAL","Vascular complications are a major cause of morbidity in type 2 diabetes mellitus. Platelet indices and ABO blood groups may be related to these complications.\n\nThis observational study will include adult patients with type 2 diabetes mellitus. Patients will be classified into those with and without vascular complications. Platelet indices (MPV, PDW) and ABO blood groups will be assessed.","Adult patients with type 2 diabetes mellitus attending the Internal Medicine Department and Diabetes Center at Assiut University Hospital.",[36,39],{"label":37,"type":29,"description":38,"interventionNames":29},"T2DM with Vascular Complications","Patients with type 2 diabetes mellitus who have microvascular or macrovascular complications.",{"label":40,"type":29,"description":41,"interventionNames":29},"T2DM without Vascular Complications","Patients with type 2 diabetes mellitus who have no microvascular or macrovascular complications.",[43],{"name":44,"affiliation":45,"role":46},"Lobna F El-toony","Internal Medicine Department, Assiut University Hospitals","STUDY_CHAIR",[48],{"name":49,"role":50,"phone":51,"phoneExt":29,"email":52},"Nehla S Mohamed, Resident","CONTACT","01023327969","Nehal.18313533@med.aun.edu.eg",{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"PRINCIPAL_INVESTIGATOR","Nehal Sayed Mohammed Sayed","Resident Physician, Department of Internal Medicine","100658121","platelet-indices-and-blood-groups-in-type-2-diabetes-vascular-complications-100658121",false,"NCT07847099","Platelet Indices and Blood Groups in Type 2 Diabetes Vascular Complications","Association of Platelet Indices and Blood Groups With Vascular Complications in Patients With Type 2 Diabetes Mellitus","Inclusion Criteria:\n\n* Age 18 years or older\n* Confirmed diagnosis of type 2 diabetes mellitus according to ADA criteria\n* Written informed consent\n\nExclusion Criteria:\n\n* Type 1 diabetes mellitus\n* Gestational diabetes\n* Acute infection or sepsis\n* Hematological disorders affecting platelet count or function\n* Malignancy\n* Chronic liver disease\n* Autoimmune diseases\n* Current anticoagulant or antiplatelet therapy\n* Recent major surgery or trauma\n* Pregnancy","ALL","18 Years",{"count":67,"type":68},100,"ESTIMATED","OBSERVATIONAL","This cross-sectional study aims to evaluate the association of platelet indices and ABO blood groups with vascular complications in patients with type 2 diabetes mellitus.",[72,73],"Type 2 Diabetes Mellitus","Vascular Complications",[75,76,77,78,79],"Platelet indices","MPV","Type 2 diabetes","ABO blood group","Assiut","NOT_YET_RECRUITING","2026-09-23",{"date":83,"type":84},"2026-09-29","ACTUAL",{"date":86,"type":68},"2026-09-26",{"date":88,"type":68},"2028-03-25",{"name":5,"class":6}]